Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
The Journal of Antimicrobial Chemotherapy|July 6, 2019
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimenAnders Thorsted, Anders N Kristoffersson, Sabine F Maarbjerg, et al.Lipids|July 26, 2003
Impact of dietary FA and energy restriction on plasma leptin and ob gene expression in miceSøren Gregersen, Janus L Thomsen, Per B Jeppesen, et al.Mediators of Inflammation|September 10, 2020
Circulating Inflammatory Markers Are Inversely Associated with Heart Rate Variability Measures in Type 1 DiabetesAnne-Marie L Wegeberg, Tina Okdahl, Tina Fløyel, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 17, 2021
Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic RetinopathyThomas Arendt Nielsen, Rok Sega, Carl Uggerhøj Andersen, et al.Diabetes Research and Clinical Practice|October 23, 2020
Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetesAnne-Marie Wegeberg, Elin D Lunde, Sam Riahi, et al.Antimicrobial Agents and Chemotherapy|September 10, 2015
Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?Kristina Öbrink-Hansen, Rasmus Vestergaard Juul, Merete Storgaard, et al.Therapeutic Advances in Drug Safety|October 5, 2020
Effects of stratified medication review in high-risk patients at admission to hospital: a randomised controlled trialDorthe Krogsgaard Bonnerup, Marianne Lisby, Eva Aggerholm Sædder, et al.Diabetes|April 28, 2004
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetesKristine B Degn, Claus B Juhl, Jeppe Sturis, et al.Journal of Diabetes and Its Complications|May 1, 2024
Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinicHatice Isik Mizrak, Huda Kufaishi, Sofie Korsgaard Hecquet, et al.Clinical Endocrinology|June 5, 2020
Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetesTina Okdahl, Christina Brock, Tina Fløyel, et al.Pageof 12